Alyeska Investment Group
LYRA

Alyeska Investment Group’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Alyeska Investment Group’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,617
Closed -$474K – 605
2023
Q3 		$512K Sell
2,617
-7,012
-73% -$1.25M ﹤0.01% 449
2023
Q2 		$1.96M Buy
+9,629
New +$1.34M 0.01% 410

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's LYRA Position: Q4 2023 in Review

Alyeska Investment Group sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2023, closing a stake of 2,617 shares — an estimated $474K sold.

Alyeska Investment Group first reported a position in LYRA in Q2 2023 and held it in 2 quarters. The position peaked at $1.96M in Q2 2023. 60 funds tracked by Wall St. Rank hold LYRA as of Q4 2023.

  • Alyeska Investment Group reported no remaining LYRA THERAPEUTICS INC position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 2,617 LYRA THERAPEUTICS INC shares in Q4 2023, an estimated $474K.
  • Alyeska Investment Group first reported a position in LYRA THERAPEUTICS INC in Q2 2023 and held it in 2 quarters.
  • Alyeska Investment Group's LYRA THERAPEUTICS INC position peaked at $1.96M in Q2 2023.
  • 60 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.